The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000277.3(PAH):c.1130A>G (p.Tyr377Cys)

CA229357

102534 (ClinVar)

Gene: PAH
Condition: phenylketonuria
Inheritance Mode: Autosomal recessive inheritance
UUID: 8cfc0af2-0d67-45a5-a855-7b335c37f5f1
Approved on: 2022-03-11
Published on: 2022-03-11

HGVS expressions

NM_000277.3:c.1130A>G
NM_000277.3(PAH):c.1130A>G (p.Tyr377Cys)
NC_000012.12:g.102843715T>C
CM000674.2:g.102843715T>C
NC_000012.11:g.103237493T>C
CM000674.1:g.103237493T>C
NC_000012.10:g.101761623T>C
NG_008690.1:g.78888A>G
NG_008690.2:g.119696A>G
ENST00000553106.6:c.1130A>G
ENST00000307000.7:c.1115A>G
ENST00000549247.6:n.889A>G
ENST00000551114.2:n.792A>G
ENST00000553106.5:c.1130A>G
ENST00000635477.1:n.234A>G
ENST00000635528.1:n.645A>G
NM_000277.1:c.1130A>G
NM_000277.2:c.1130A>G
NM_001354304.1:c.1130A>G
NM_001354304.2:c.1130A>G
More

Likely Pathogenic

Met criteria codes 5
PP3 PM5 PM3 PM2 PP4_Moderate

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Phenylketonuria VCEP
The NM_000277.2(PAH):c.1130A>G (p.Tyr377Cys) variant is a missense variant in exon 11/13 of PAH. The variant has been previously reported in trans with p.R243* (Pathogenic in ClinVar and per ClinGen PAH VCEP) in a PKU patient (plasma Phe 765 umol/L); BH4 deficiency was excluded by analysis of urinary pterins and dihydropterine reductase assays (PMID: 22526846) (PM3; PP4_Moderate). One heterozygote and zero homozygotes are present for the variant in gnomAD, corresponding to a global frequency of 0.00000398 and a maximum population frequency (non-Finnish European) of 0.00000879, under the frequency cutoff of 0.0002 for use of PM2 (PM2). The variant is predicted damaging by multiple in-silico missense predictors, including REVEL (REVEL score 0.849), so PP3 is met. PM5 also applies because a different missense variant at the same amino acid residue, p.Y377D, qualifies as Likely Pathogenic: the p.Y377D variant has been previously reported in trans with the known pathogenic c.1066-11G>A splicing mutation in a proband with PKU (plasma Phe 20-30mg/dL; BH4 formally excluded by urinary pterin and DHPR analysis) (PMID: 21890392) (PM3; PP4_Moderate), is absent in ethnically diverse control databases, including gnomAD/ExAC, 1000 Genomes, and ESP (PM2), and is predicted damaging by multiple in-silico missense predictors, including REVEL (REVEL score 0.874) (PP3). Classification: Likely Pathogenic Supporting Criteria: PM2; PM3; PP4_Moderate; PM5, PP3
Met criteria codes
PP3
SIFT predicts tolerated, other software predicts damaging. REVEL=0.849 (includes SIFT) so okay to apply PP3 per PAH VCEP.
PM5
PM5 also applies because a different missense variant at the same amino acid residue, p.Y377D, qualifies as Likely Pathogenic: the p.Y377D variant has been previously reported in trans with the known pathogenic c.1066-11G>A splicing mutation in a proband with PKU (plasma Phe 20-30mg/dL; BH4 formally excluded by urinary pterin and DHPR analysis) (PMID: 21890392) (PM3; PP4_Moderate), is absent in ethnically diverse control databases, including gnomAD/ExAC, 1000 Genomes, and ESP (PM2), and is predicted damaging by multiple in-silico missense predictors, including REVEL (REVEL score 0.874) (PP3).
PM3
The variant has been previously reported in trans with p.R243* (Pathogenic in ClinVar and per ClinGen PAH VCEP) in a PKU patient (plasma Phe 765 umol/L); BH4 deficiency was excluded by analysis of urinary pterins and dihydropterine reductase assays (PMID: 22526846) (PM3; PP4_Moderate).
PM2
One heterozygote and zero homozygotes are present for the variant in gnomAD, corresponding to a global frequency of 0.00000398 and a maximum population frequency (non-Finnish European) of 0.00000879, under the frequency cutoff of 0.0002 for use of PM2 (PM2).
PP4_Moderate
The variant has been previously reported in trans with p.R243* (Pathogenic in ClinVar and per ClinGen PAH VCEP) in a PKU patient (plasma Phe 765 umol/L); BH4 deficiency was excluded by analysis of urinary pterins and dihydropterine reductase assays (PMID: 22526846) (PM3; PP4_Moderate).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.